Literature DB >> 17823790

Acute myocarditis after massive phenelzine overdose.

W Stephen Waring1, William A H Wallace.   

Abstract

BACKGROUND: Monoamine oxidase inhibitors (MAOIs) are uncommonly used due to their high frequency of adverse effects, including tachycardia and hypertension. Recently, there has been renewed interest in the role of this class of drugs in treating a variety of psychiatric disorders. The clinical features of MAOI overdose are poorly characterised. This paper describes a novel cardiac complication of phenelzine toxicity in a previously healthy young adult with no history of cardiovascular disease.
METHODS: A 23-year-old woman presented to hospital after massive phenelzine overdose, and the clinical features and pathological findings are discussed in light of existing literature.
RESULTS: Clinical features of phenelzine toxicity included reduced consciousness level, seizures, and tachycardia, in keeping with previous reports. Unexpectedly, the patient developed severe and unexplained hypotension and impaired left ventricular function, and died 3 days after initial presentation. Post-mortem examination confirmed high serum phenelzine concentrations (4.1 mg/L) and histopathological features that were consistent with drug-induced acute myocarditis.
CONCLUSION: Acute myocarditis was attributed to phenelzine in the absence of any plausible alternative explanation. This possible complication should be considered in patients who develop unexplained hypotension after phenelzine overdose.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17823790     DOI: 10.1007/s00228-007-0360-y

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  17 in total

1.  Coadministration of phenelzine and methylphenidate for treatment-resistant depression.

Authors:  Angela Shelton Clauson; Ellie S Elliott; Brian D Watson; Journey Treacy
Journal:  Ann Pharmacother       Date:  2004-01-23       Impact factor: 3.154

2.  Incidence of myocarditis. A 10-year autopsy study from Malmö, Sweden.

Authors:  M B Gravanis; N H Sternby
Journal:  Arch Pathol Lab Med       Date:  1991-04       Impact factor: 5.534

3.  Fatal cephalosporin-induced acute hypersensitivity myocarditis.

Authors:  Kudakwashe R Chikwava; Van H Savell; Theonia K Boyd
Journal:  Pediatr Cardiol       Date:  2006-11-16       Impact factor: 1.655

4.  Quantitative determination of phenelzine in human fluids by gas chromatography with nitrogen specific detection.

Authors:  M Lichtenwalner; M McMullin; D Hardy; F Rieders
Journal:  J Anal Toxicol       Date:  1988 Mar-Apr       Impact factor: 3.367

5.  Clinical features and treatment of overdosage of monoamine oxidase inhibitors and their interaction with other psychotropic drugs.

Authors:  E Ciocatto; G Fagiano; G L Bava
Journal:  Resuscitation       Date:  1972-03       Impact factor: 5.262

Review 6.  Myocarditis, pericarditis and cardiomyopathy in patients treated with clozapine.

Authors:  P M Wehmeier; P Heiser; H Remschmidt
Journal:  J Clin Pharm Ther       Date:  2005-02       Impact factor: 2.512

Review 7.  Eosinophilic myocarditis: case series and review of literature.

Authors:  Abdullah M Al Ali; Lynn P Straatman; Michael F Allard; Andrew P Ignaszewski
Journal:  Can J Cardiol       Date:  2006-12       Impact factor: 5.223

8.  Therapeutic re-orientation in some depressive states: clinical evaluation of a new mono-amine oxidase inhibitor (W-1554-A, phenelzine, Nardil).

Authors:  W FURST
Journal:  Am J Psychiatry       Date:  1959-11       Impact factor: 18.112

9.  Two fatalities involving phenelzine.

Authors:  M R Lichtenwalner; R G Tully; R D Cohn; R D Pinder
Journal:  J Anal Toxicol       Date:  1995 Jul-Aug       Impact factor: 3.367

10.  Quetiapine for insomnia associated with refractory depression exacerbated by phenelzine.

Authors:  Kenneth N Sokolski; Brenda J Brown
Journal:  Ann Pharmacother       Date:  2006-02-14       Impact factor: 3.154

View more
  5 in total

1.  Phenelzine (monoamine oxidase inhibitor) increases production of nitric oxide and proinflammatory cytokines via the NF-κB pathway in lipopolysaccharide-activated microglia cells.

Authors:  Hwan-Suck Chung; Hyunseong Kim; Hyunsu Bae
Journal:  Neurochem Res       Date:  2012-07-05       Impact factor: 3.996

2.  Monoamine oxidase A and organic cation transporter 3 coordinate intracellular β1AR signaling to calibrate cardiac contractile function.

Authors:  Ying Wang; Meimi Zhao; Bing Xu; Sherif M F Bahriz; Chaoqun Zhu; Aleksandra Jovanovic; Haibo Ni; Ariel Jacobi; Nina Kaludercic; Fabio Di Lisa; Johannes W Hell; Jean C Shih; Nazareno Paolocci; Yang K Xiang
Journal:  Basic Res Cardiol       Date:  2022-07-17       Impact factor: 12.416

3.  Body fat reduction without cardiovascular changes in mice after oral treatment with the MAO inhibitor phenelzine.

Authors:  Christian Carpéné; Josep Mercader; Sophie Le Gonidec; Stéphane Schaak; Jeanne Mialet-Perez; Alexia Zakaroff-Girard; Jean Galitzky
Journal:  Br J Pharmacol       Date:  2018-05-06       Impact factor: 8.739

4.  Clinical use of antidepressant therapy and associated cardiovascular risk.

Authors:  W Stephen Waring
Journal:  Drug Healthc Patient Saf       Date:  2012-08-17

Review 5.  Cardiovascular considerations in antidepressant therapy: an evidence-based review.

Authors:  Habibeh Yekehtaz; Mehdi Farokhnia; Shahin Akhondzadeh
Journal:  J Tehran Heart Cent       Date:  2013-10-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.